Close

Novartis (NVS) Announces Receipt of Three New FDA Approvals for Expanded Use of Ilaris

Go back to Novartis (NVS) Announces Receipt of Three New FDA Approvals for Expanded Use of Ilaris
NOVARTIS AG (NYSE: NVS) Delayed: 95.88 --0 (-0%)
Previous Close $95.88    52 Week High $89.15 
Open $95.88    52 Week Low $69.84 
Day High $95.88    P/E N/A 
Day Low $95.88    EPS $0.00 
Volume 3,093